These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15899029)

  • 1. The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis.
    Keith JC; Albert LM; Leathurby Y; Follettie M; Wang L; Borges-Marcucci L; Chadwick CC; Steffan RJ; Harnish DC
    Arthritis Res Ther; 2005; 7(3):R427-38. PubMed ID: 15899029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
    Chadwick CC; Chippari S; Matelan E; Borges-Marcucci L; Eckert AM; Keith JC; Albert LM; Leathurby Y; Harris HA; Bhat RA; Ashwell M; Trybulski E; Winneker RC; Adelman SJ; Steffan RJ; Harnish DC
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2543-8. PubMed ID: 15699342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
    Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
    Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritis.
    Caggiano TJ; Brazzale A; Ho DM; Kraml CM; Trybulski E; Chadwick CC; Chippari S; Borges-Marcucci L; Eckert A; Keith JC; Kenney T; Harnish DC
    J Med Chem; 2007 Nov; 50(22):5245-8. PubMed ID: 17902637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-endorphin ameliorates synovial cell hyperfunction in the collagen-induced arthritis rat model by specific downregulation of NF-kappa B activity.
    Yin H; Zhang F; Yu M; Cheng H; Lin J; Gao Y; Han B; Zhu L
    Neuroendocrinology; 2005; 81(1):10-8. PubMed ID: 15802927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS.
    Guo X; Pan Y; Xiao C; Wu Y; Cai D; Gu J
    Int J Rheum Dis; 2012 Jun; 15(3):322-9. PubMed ID: 22709495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
    Steffan RJ; Matelan E; Ashwell MA; Moore WJ; Solvibile WR; Trybulski E; Chadwick CC; Chippari S; Kenney T; Eckert A; Borges-Marcucci L; Keith JC; Xu Z; Mosyak L; Harnish DC
    J Med Chem; 2004 Dec; 47(26):6435-8. PubMed ID: 15588074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norisoboldine inhibits the production of interleukin-6 in fibroblast-like synoviocytes from adjuvant arthritis rats through PKC/MAPK/NF-κB-p65/CREB pathways.
    Wei Z; Wang F; Song J; Lu Q; Zhao P; Xia Y; Chou G; Wang Z; Dai Y
    J Cell Biochem; 2012 Aug; 113(8):2785-95. PubMed ID: 22473817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossroads of estrogen receptor and NF-kappaB signaling.
    Biswas DK; Singh S; Shi Q; Pardee AB; Iglehart JD
    Sci STKE; 2005 Jun; 2005(288):pe27. PubMed ID: 15956359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.
    Wakamatsu K; Nanki T; Miyasaka N; Umezawa K; Kubota T
    Arthritis Res Ther; 2005; 7(6):R1348-59. PubMed ID: 16277688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
    Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
    Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products.
    Okamoto H; Katagiri Y; Kiire A; Momohara S; Kamatani N
    J Rheumatol; 2008 May; 35(5):752-6. PubMed ID: 18322992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts.
    Chi PL; Luo SF; Hsieh HL; Lee IT; Hsiao LD; Chen YL; Yang CM
    Arthritis Rheum; 2011 Oct; 63(10):2905-17. PubMed ID: 21702012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
    J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.